HomeInsightsShare Holding

Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd Share Holding Pattern

stocks purchased

₹ 1.4 Cr

Volume transacted

stocks purchased

8.7 K

stocks traded

Last Updated time: 19 Sep 9.00 AM

Promoters Holdings Over Time

Key Highlights

  • Promoters increased their stake in the company by 0.00% from March 2024 to June 2024. Mutual funds increased their stake in the company by 0.36% from March 2024 to June 2024.
  • FIIs/FPIs decreased their stake in the company by 0.39% from March 2024 to June 2024.

Latest Shareholding

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 20241651.15
18 Sep 20241645.05
17 Sep 20241713.35
16 Sep 20241741.85
13 Sep 20241752.35
12 Sep 20241747.9
11 Sep 20241727.75
10 Sep 20241726.6
09 Sep 20241708.95
06 Sep 20241702.4

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals to convene AGM

Glenmark Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wi...

Read more

31 Aug 202416:40

News

Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session

Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoti...

Read more

21 Aug 202413:00

News

Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution

Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalm...

Read more

19 Aug 202409:09

News

Glenmark Pharma gains after American subsidiary launches Olopatadine generic

The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed ...

Read more

19 Aug 202409:29

News

Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session

Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting...

Read more

19 Aug 202413:05

News

Glenmark Pharma gains on reporting muti-fold jump in Q1 PAT

Revenue from operations increased 6.85% year on year (YoY) to Rs 3,244.19 crore in the qua...

Read more

16 Aug 202410:22

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

Credit Report 2023

dropdown
download

Concalls

June 2024

TranscriptPPT

May 2024

PPT

Sep 2023

PPT

Feb 2022

PPT

Nov 2021

PPT

Aug 2021

PPT

May 2021

PPT

FAQs for EPS of Glenmark Pharmaceuticals Ltd

On what factors does the shareholding pattern of Glenmark Pharmaceuticals Ltd change frequently?

The shareholding pattern of Glenmark Pharmaceuticals Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Glenmark Pharmaceuticals Ltd's shareholding pattern updated?

The Glenmark Pharmaceuticals Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Glenmark Pharmaceuticals Ltd?

Categories included in the shareholding pattern of Glenmark Pharmaceuticals Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Glenmark Pharmaceuticals Ltd important for investors?

The shareholding pattern of Glenmark Pharmaceuticals Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Glenmark Pharmaceuticals Ltd?

The latest shareholding pattern of Glenmark Pharmaceuticals Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*